Marijuana Inc. (MAJI)

OTCMKTS · Delayed Price · Currency is USD
0.1780
+0.0080 (4.71%)
May 19, 2025, 4:00 PM EDT
69.52%
Market Cap 6.25M
Revenue (ttm) n/a
Net Income (ttm) -854.02K
Shares Out 35.09M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,200
Average Volume 117,895
Open 0.1800
Previous Close 0.1700
Day's Range 0.1780 - 0.1850
52-Week Range 0.0045 - 0.3199
Beta -4.24
RSI 50.56
Earnings Date n/a

About Marijuana

Marijuana Inc. distributes cannabis products in the United States. The company was formerly known as GRN Holding Corporation and changed its name to Marijuana Inc. in October 2024. Marijuana Inc. was founded in 2010 and is based in Estero, Florida. [Read more]

Sector Healthcare
Founded 2010
Country United States
Stock Exchange OTCMKTS
Ticker Symbol MAJI
Full Company Profile

Financial Performance

Financial Statements

News

Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application

- Rigorous humanized mouse model enhances credibility and translatability of results - Key preclinical data to support FDA Orphan Drug Application - In vitro success signals potential for exosome-base...

20 days ago - Accesswire

Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview

A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a ...

4 weeks ago - Accesswire

Exousia Pro Offers Guidance on New Subdivisions

ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is p...

4 weeks ago - Accesswire

Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show

Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech comp...

5 weeks ago - Accesswire

Exousia Pro Issues Update on Name Change

ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other dis...

6 weeks ago - Accesswire

Exousia Pro Has Appointed Matthew Dwyer As Its New President

ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

6 weeks ago - Accesswire

Exousia Pro Issues and Update on its FDA Orphan Drug Status

ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

6 weeks ago - Accesswire

Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun

Exousia Pro will be sending out samples to clients expected to place orders ORLANDO, FL / ACCESS Newswire / March 25, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., announces the offici...

7 weeks ago - Accesswire

Exousia Has Successfully Renegotiated Its License Agreement

ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

2 months ago - Accesswire